
Jai Radhakrishnan, MD, MBBS, MS, FASN, discusses why IgG4-related kidney disease is often missed and what the MITIGATE subgroup data presented at ASN Kidney Week 2026 show.
Moses Zonana, CEO of Compliance Meds Technologies, discusses ways technology can be utilized to monitor adherence.
Zonana: I have a couple of our products here and one of them is called CleverCap PRO. So, Clever Cap Pro basically tracks every time a pill is dispensed, and it controls for the dose, and tracks at the pill level of granularity—–which means that every time a pill comes out it time stamps the event and sends it to the cloud instantly. If a patient either underdoses or overdoses, someone will be monitoring and taking action accordingly. So, that can initiate an engagement call, it can initiate an educational call, it can initiate a video being sent, and then you take decisions before it’s too late.




